Literature DB >> 30373790

Successful Treatment of Saksenaea sp. Osteomyelitis by Conservative Surgery and Intradiaphyseal Incorporation of Amphotericin B Cement Beads.

Perrine Parize1, Anne-Claire Mamez2, Dea Garcia-Hermoso3, Valérie Dumaine4, Sylvain Poirée5, Catherine Kauffmann-Lacroix6, Vincent Jullien7, Olivier Lortholary2,3, Fanny Lanternier2,3.   

Abstract

Osteoarticular mucormycosis cases are quite rare and challenging infections that are mostly due to direct inoculation during traumatic injury among immunocompetent patients. Classic management includes a combination of aggressive surgical debridement, which may lead to amputation, and long-term systemic liposomal amphotericin B therapy. This article describes the successful treatment of Saksenaea sp. osteomyelitis in a patient with diabetes mellitus, using a combination of systemic antifungal therapy and conservative surgery with insertion of amphotericin-impregnated cement beads.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Mucoraleszzm321990; amphotericin B; antifungal agents; osteomyelitis

Mesh：

Substances：

Year:  2018        PMID： 30373790      PMCID： PMC6325185          DOI： 10.1128/AAC.01006-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Amphotericin-impregnated polymethylmethacrylate beads as treatment for soft tissue mucormycosis.

Authors:  Stephanie F Heller; Alberto Pochettino; Mariela Rivera; Henry J Schiller
Journal:  Surgery       Date:  2017-05-24       Impact factor: 3.982

2.  Successful surgical and medical treatment of rhizopus osteomyelitis following hematopoietic cell transplantation.

Authors:  Nikita Vashi; Raffi Avedian; Janice Brown; Sally Arai
Journal:  Orthopedics       Date:  2012-10       Impact factor: 1.390

3.  Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

Authors:  A Skiada; L Pagano; A Groll; S Zimmerli; B Dupont; K Lagrou; C Lass-Florl; E Bouza; N Klimko; P Gaustad; M Richardson; P Hamal; M Akova; J F Meis; J-L Rodriguez-Tudela; E Roilides; A Mitrousia-Ziouva; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2011-07-01       Impact factor: 8.067

4.  Saksenaea vasiformis infections: case report and literature review.

Authors:  William Vega; Margot Orellana; Luis Zaror; Josepa Gené; Josep Guarro
Journal:  Mycopathologia       Date:  2006-10       Impact factor: 2.574

5.  In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

Authors:  Qiu N Sun; Annette W Fothergill; Dora I McCarthy; Michael G Rinaldi; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 6.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Saksenaea vasiformis osteomyelitis.

Authors:  P F Pierce; M B Wood; G D Roberts; R H Fitzgerald; C Robertson; R S Edson
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

8.  Fungal Planet description sheets: 558-624.

Authors:  P W Crous; M J Wingfield; T I Burgess; G E St J Hardy; P A Barber; P Alvarado; C W Barnes; P K Buchanan; M Heykoop; G Moreno; R Thangavel; S van der Spuy; A Barili; S Barrett; S O Cacciola; J F Cano-Lira; C Crane; C Decock; T B Gibertoni; J Guarro; M Guevara-Suarez; V Hubka; M Kolařík; C R S Lira; M E Ordoñez; M Padamsee; L Ryvarden; A M Soares; A M Stchigel; D A Sutton; A Vizzini; B S Weir; K Acharya; F Aloi; I G Baseia; R A Blanchette; J J Bordallo; Z Bratek; T Butler; J Cano-Canals; J R Carlavilla; J Chander; R Cheewangkoon; R H S F Cruz; M da Silva; A K Dutta; E Ercole; V Escobio; F Esteve-Raventós; J A Flores; J Gené; J S Góis; L Haines; B W Held; M Horta Jung; K Hosaka; T Jung; Ž Jurjević; V Kautman; I Kautmanova; A A Kiyashko; M Kozanek; A Kubátová; M Lafourcade; F La Spada; K P D Latha; H Madrid; E F Malysheva; P Manimohan; J L Manjón; M P Martín; M Mata; Z Merényi; A Morte; I Nagy; A-C Normand; S Paloi; N Pattison; J Pawłowska; O L Pereira; M E Petterson; B Picillo; K N A Raj; A Roberts; A Rodríguez; F J Rodríguez-Campo; M Romański; M Ruszkiewicz-Michalska; B Scanu; L Schena; M Semelbauer; R Sharma; Y S Shouche; V Silva; M Staniaszek-Kik; J B Stielow; C Tapia; P W J Taylor; M Toome-Heller; J M C Vabeikhokhei; A D van Diepeningen; N Van Hoa; Van Tri M; N P Wiederhold; M Wrzosek; J Zothanzama; J Z Groenewald
Journal:  Persoonia       Date:  2017-06-20       Impact factor: 11.051

9.  ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.

Authors:  Frederic Tissot; Samir Agrawal; Livio Pagano; Georgios Petrikkos; Andreas H Groll; Anna Skiada; Cornelia Lass-Flörl; Thierry Calandra; Claudio Viscoli; Raoul Herbrecht
Journal:  Haematologica       Date:  2016-12-23       Impact factor: 9.941

10.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Authors:  O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; T Freiberger; J Guinea; J Guarro; S de Hoog; W Hope; E Johnson; S Kathuria; M Lackner; C Lass-Flörl; O Lortholary; J F Meis; J Meletiadis; P Muñoz; M Richardson; E Roilides; A M Tortorano; A J Ullmann; A van Diepeningen; P Verweij; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067
View more
  2 in total

Review 1.  Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement.

Authors:  Richard H Drew; John R Perfect
Journal:  J Fungi (Basel)       Date:  2022-02-21

2.  Saksenaea dorisiae sp. nov., a New Opportunistic Pathogenic Fungus from Europe.

Authors:  Roman Labuda; Andreas Bernreiter; Doris Hochenauer; Christoph Schüller; Alena Kubátová; Joseph Strauss; Martin Wagner
Journal:  Int J Microbiol       Date:  2019-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.